22-19941727-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006440.5(TXNRD2):āc.77T>Cā(p.Val26Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000491 in 1,487,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V26G) has been classified as Likely benign.
Frequency
Consequence
NM_006440.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TXNRD2 | NM_006440.5 | c.77T>C | p.Val26Ala | missense_variant | 1/18 | ENST00000400521.7 | NP_006431.2 | |
COMT | NM_000754.4 | c.-262A>G | upstream_gene_variant | ENST00000361682.11 | NP_000745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TXNRD2 | ENST00000400521.7 | c.77T>C | p.Val26Ala | missense_variant | 1/18 | 1 | NM_006440.5 | ENSP00000383365.1 | ||
COMT | ENST00000361682.11 | c.-262A>G | upstream_gene_variant | 1 | NM_000754.4 | ENSP00000354511.6 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151770Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000109 AC: 1AN: 91588Hom.: 0 AF XY: 0.0000193 AC XY: 1AN XY: 51724
GnomAD4 exome AF: 0.0000539 AC: 72AN: 1335474Hom.: 0 Cov.: 31 AF XY: 0.0000531 AC XY: 35AN XY: 658686
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151770Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74136
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 18, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with TXNRD2-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 26 of the TXNRD2 protein (p.Val26Ala). - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 22, 2022 | The p.V26A variant (also known as c.77T>C), located in coding exon 1 of the TXNRD2 gene, results from a T to C substitution at nucleotide position 77. The valine at codon 26 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at